Navigation Links
BioAtom Inc. To Present at BIOCOM Investor Conference 2008
Date:10/26/2008

SAN DIEGO, Oct. 27 /PRNewswire/ -- BioAtom Inc. (private) announced today that it will present at the 3rd annual BIOCOM Investor Conference on Tuesday, October 28, 2008 at 2:30 PM PDT (5:30 PM EDT) at the Hyatt Regency La Jolla in San Diego, California.

Myron Karasik, M.B.A., C.M.C., Director of Finance, will present an overview of Medical Division of BioAtom Inc. of Costa Mesa, CA, dedicated to development and commercialization of Neutron Cancer Diagnostics. Its ONCOSENSOR(TM), a nanotechnology probe, will undergo in vivo evaluation at Center for Functional Onco Imaging, UC Irvine, in collaboration with Radiation Oncology Group, Long Beach Memorial Hospital.

From Bomb Detector to Cancer Diagnostic Probe. Malignant tumors are chemically different from normal tissue. ONCOSENZOR(TM) can non-invasively detect in vitro chemical differences as small as 1 atom/molecule. Its core technology was developed under US Army contracts for non-intrusive detectors of bioagents and explosives in a previous company (no longer in existence), by co-founders of BioAtom, at a cost to shareholders of over $40 million.

Our mission is to provide an early warning, walk-in, painless (non-invasive) and "instant" (online) cancer diagnosis aid that is a quantum leap ahead of competing firms. Operating in tandem with any one of the imaging probes, we hope to ultimately achieve needle-less biopsy. The method has the potential for forewarning of stroke, Alzheimer, and cardiovascular diseases.

Marketing of ONCOSENZOR(TM) to animal clinics, a $13 Billion/year market, does not require FDA approval.

Anna Radovic, Ph.D., 36, President and Chief Scientific Officer, an international cancer researcher and co-patentee, was first to irradiate DNA by neutrons. Christian Druey, B.E.E., 38, has been instrumental in commercialization of medical imaging and explosive detection devices. Bogdan Maglich, Ph.D., CTO and Chairman, the inventor of the core technology, has been
'/>"/>

SOURCE BioAtom Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Oncothyreon to present at BIO Investor Forum 2008
2. China Yingxia to Present at Rodman & Renshaw Annual Global Investment Conference
3. Significant Anti-Tumor Activity and Extended Half-Life of NKTR-102 (PEG-irinotecan) Highlighted in Phase 1 Data Presented at EORTC-NCI-AACR Symposium
4. Amylin Pharmaceuticals to Present at BIOCOM Investor Conference
5. Oncolytics Biotech Inc. Collaborators to Present Combination REOLYSIN(R) and Paclitaxel/Carboplatin Results at iSBTc Annual Meeting
6. Oncolytics Biotech Inc. Collaborators to Present Combination REOLYSIN(R) and Docetaxel Results at iSBTc Annual Meeting
7. MedImmune Presents Data Highlighting its Progressive Inflammatory Disease Portfolio at the 72nd Annual Meeting of the American College of Rheumatology
8. New Clinical Studies Presented at the American Society of Anesthesiology (ASA) Annual Meeting Show Masimo Technologies Provide Advanced Clinical Intelligence
9. Celator(R) Pharmaceuticals To Present at 2008 BIO Investor Forum
10. Rosetta Genomics to Present at the Upcoming EORTC-NCI-ASCO Annual Meeting on "Molecular Markers in Cancer"
11. Oncolytics Biotech Inc. Collaborators Present Reovirus and Melanoma Research at EORTC-NCI-AACR Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... Bayer CropScience will honor Illinois beekeeper Steve ... Leadership Award. The award will be announced at Bayer’s ... D.C., an event where supporters of pollinator health celebrate ... , The Bayer Bee Care Community Leadership Award ... honey bee colony to benefit their community. Applicants are ...
(Date:6/19/2013)... -- Biotechnology industry pioneer Amgen (NASDAQ: ... BlackLine Systems  and enterprise application software leader SAP ... next week entitled "No Account Left Behind!  ... Help Keep Its Account Reconciliations in Good Shape ."  ... The webinar, geared at finance, accounting, audit and compliance managers ...
(Date:6/19/2013)... Indiana (PRWEB) June 19, 2013 ... joined the speaking faculty at 2013’s BioLogistics Summit ... The conference, coordinated by Cold Chain IQ and ... biologics. This “complexity” is, in part, attributed to ... , “Implicit within these trends is an ...
(Date:6/19/2013)... Applied Rigaku Technologies, Inc. is pleased to publish ... sulfur in ultra-low sulfur diesel (ULSD) using the new ... . The analysis detailed in Rigaku Application Note 1272 ... International Standard specifies an energy dispersive X-ray fluorescence (EDXRF) ... automotive gasoline. , Regulations around the world have limited ...
Breaking Biology Technology:Community Mentor Wins Inaugural Bayer CropScience Bee Care Leadership Award 2Community Mentor Wins Inaugural Bayer CropScience Bee Care Leadership Award 3Community Mentor Wins Inaugural Bayer CropScience Bee Care Leadership Award 4Amgen Joins BlackLine Systems, SAP for Webinar on Automating Account Reconciliations 2Amgen Joins BlackLine Systems, SAP for Webinar on Automating Account Reconciliations 3Amgen Joins BlackLine Systems, SAP for Webinar on Automating Account Reconciliations 4BioConvergence® Presents at BioLogistics Summit on Risk Matrix for Biosamples during Shipment 2Rigaku Publishes New Application Note for Analysis of ULSD Per ISO 13032 2
... in early-stage Wisconsin companies topped $100 million last year, but ... interesting investment patterns. , ,The figures were outlined in a ... for 2006, which was produced by NorthStar Economics , ... Department of Financial Institutions . , ,While the total ...
... to add the Olympics to their list of great ... more than just a third-party Wi-Fi agreement. The City ... Wi-Fi and into the real competition of global cities ... Look around, Wi-Fi projects are failing , ,Anyone ...
... This is part II of a two-part column on ... focused on the recent controversy over Avandia, GlaxoSmithKline's diabetes drug. ... be so deeply integral to the system that it might be ... For much of its history, the Food and Drug Administration's ...
Cached Biology Technology:Breaking down Wisconsin's angel capital numbers 2Breaking down Wisconsin's angel capital numbers 3No network infrastructure, no Olympics, no nothing 2No network infrastructure, no Olympics, no nothing 3No network infrastructure, no Olympics, no nothing 4No network infrastructure, no Olympics, no nothing 5No network infrastructure, no Olympics, no nothing 6Reforming FDA: Focus on safety, let market judge efficacy 2Reforming FDA: Focus on safety, let market judge efficacy 3Reforming FDA: Focus on safety, let market judge efficacy 4Reforming FDA: Focus on safety, let market judge efficacy 5Reforming FDA: Focus on safety, let market judge efficacy 6
(Date:6/18/2013)... National Institutes of Health has awarded $12.7 million ... selection of pharmaceutical industry compounds to explore new ... Alzheimer,s disease, Duchenne muscular dystrophy and schizophrenia. The ... for Existing Molecules, is led by the National ... by the NIH Common Fund. , The process ...
(Date:6/18/2013)... June 18, 2013: The Association for Molecular Pathology is ... American Societies for Experimental Biology (FASEB) on July 1, ... on June 3, 2013. , The 26 constituent ... share a common vision for the advancement of research ... and translational research is more important now than ever," ...
(Date:6/18/2013)... that between 5% and 10% of breast and ovarian ... that these tumours are attributable to inherited mutations from ... In patients with these mutations, PARP inhibitors, which are ... make them a new option for personalised cancer treatment, ... indicate that a fraction of these patients generate resistance ...
Breaking Biology News(10 mins):NIH to fund collaborations with industry to identify new uses for existing compounds 2NIH to fund collaborations with industry to identify new uses for existing compounds 3NIH to fund collaborations with industry to identify new uses for existing compounds 4An article in 'Cell' reveals a new resistance mechanism to chemotherapy in breast and ovarian cancer 2
... renews itself may be simpler than what scientists had been ... of The Journal of Biological Chemistry, provides new information on ... significantly affect the way physicians make livers regrow in patients ... , "The human liver is one of the few organs ...
... do it: they simply grab carbon dioxide out of the ... as photosynthesis, the plants use light as their energy source. ... as a carbon source for their synthetic reactions, but it ... Antonietti at the Max Planck Institute for Colloids and Interfaces ...
... inhibitor of a protein that plays key roles in ... the inhibitor can halt the growth of tumors in ... are reported in companion papers reported by two collaborating ... the Research Institute of Molecular Pathology in Vienna, and ...
Cached Biology News:Liver regeneration may be simpler than previously thought 2Liver regeneration may be simpler than previously thought 3Progress toward artificial photosynthesis? 2New protein inhibitor impedes growth of cancerous cells 2
... sensitive silver stain. Reproducible ... baths or reversers needed. ... polysaccharides. Linear protein-to-stain color ... multiple gels per tray. ...
Rabbit polyclonal to Quinaldic Acid ( Abpromise for all tested applications). Antigen: Synthetic peptide Quinaldic Acid conjugated to a protein carrier....
A set of five peptides which can be used to calibrate a Matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) or Electrospray Ionization (ESI) mass spectrometer....
... CLS number is a new ... match Cornings product number. If ... order under the old Sigma-Aldrich ... service for assistance. ID clarifier: ...
Biology Products: